CE Courses

CE Courses

Troubleshooting complications of vascular access devices

Dawn Camp-Sorrell, MSN, FNP, AOCN December 15, 2011

VADs enable long-term IV therapy; however, the devices and their use pose a unique set of challenges for nurses.
 
Side-Effect Management

CIPN: Treatment preservation and prevention are the goals

Colleen H. Erb, MSN, ACNP-BC, AOCNP September 21, 2011

CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
 
CE Courses

Understanding ototoxicity risks for pediatric oncology patients

Karen MacDonald, RN, BSN, CPON July 11, 2011

Audiometric testing, awareness of the symptoms, and knowledge of which drugs are ototoxic can help protect young cancer patient's hearing.
 
CE Courses

Differentiating type is key to non-Hodgkin lymphomas

May 16, 2011

Management and prognosis for patients with NHL depend on identifying the disease type. This review discusses the diagnoses and optimal treatments.
 
CE Courses

Lynch syndrome: Identifying patients at risk for HNPCC

Cristina Polinsky, MS, CGC; Rachael Brandt, MS, CGC; Rosemarie Tucci, RN, MSN, AOCN; Terri McHugh, DO March 16, 2011

Identifying families at risk improves screening and counseling of patients at risk for hereditary nonpolyposis colorectal cancer.
 
CE Courses

Cancer-related fatigue: Elusive causes challenge treatment

January 14, 2011

Effective management of this nonspecific and varied symptom is based on the underlying mechanisms of action.
 
CE Courses

Approaches to chemotherapy-induced nausea and vomiting

December 14, 2010

Our ability to prevent acute CINV has improved greatly, but delayed CINV remains a problem.
 
CE Courses

Compassion fatigue in oncology nursing: A witness to suffering

Kerstin L. McSteen, MS, ACNS-BC, ACHPN September 27, 2010

The ability to recognize the symptoms and manage the consequences are critical to personal and professional health.
 
CE Courses

Managing EGFR inhibitor side effects in lung cancer patients

Beth Eaby-Sandy, CRNP, OCN August 01, 2010

Oncology nurses can do much to effectively use epidermal growth factor receptor inhibitors, a mainstay of lung cancer treatment.
 
CE Courses

Prevention and management of hand-foot syndromes

July 15, 2010

Hand-foot syndromes are debilitating and greatly compromise quality of life. Aggressive management can prevent treatment disruption.
 

CE UPDATE!

Oncology Nurse Advisor continuing nursing education, provided by NPHF, are now available for 2 years!

Expiration dates for these 2010 CE activities are extended one additional year from the original expiration date

The methods and terminology of cancer trials: A review

Prevention and management of hand-foot syndromes

Managing EGFR inhibitor side effects in lung cancer patients

Compassion fatigue in oncology nursing: A witness to suffering

Approaches to chemotherapy-induced nausea and vomiting

All 2011 CE activities are valid until 2013


Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions